Home Infusion Therapy Market Is Projected To Grow At A CAGR Of 8.6% Over The Coming 10 Years

Home Infusion Therapy Market Outlook

Newly-released Home Infusion Therapy industry analysis report by Fact.MR shows that global sales of Home Infusion Therapy in 2021 was held at US$ 31 Bn. With 8.6%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Bn during 2022 – 2032.

.To remain ‘ahead’ of your competitors, request a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7169

Prominent Key players of the Home Infusion Therapy market survey report:

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat
• PharMerica
• Fresenius Kabi
• ICU Medical, Inc.
• B. Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd.

Market Segments Covered in Home Infusion Therapy Industry Analysis

• By Product Type :
  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Other Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needless Connectors
• By Application Type :
  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Other Applications
• By Region :
  • North America
  • Latin America
  • Europe
  • APAC
  • MEA